BLCO
Bausch + Lomb Corporation
BLCO lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
BLCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
BLCO's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
BLCO PE Valuation
BLCO has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
BLCO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BLCO has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
BLCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.17 | — |
| Q3 2026 | -$0.31 | +$0.55 |
| Q2 2026 | -$0.48 | +$0.29 |
| Q1 2026 | -$0.62 | +$0.40 |
| Q4 2025 | -$1.02 | -$0.12 |
| Q3 2025 | -$0.86 | +$0.19 |
| Q2 2025 | -$0.77 | +$0.53 |
| Q1 2025 | -$1.02 | -$0.06 |
| Q4 2024 | -$0.90 | -$0.16 |
BLCO has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
BLCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +7.3% |
| Q2 2026 | $1.4B | +9.1% |
| Q1 2026 | $1.2B | +9.4% |
| Q4 2025 | $1.4B | +9.8% |
| Q3 2025 | $1.3B | +7.1% |
| Q2 2025 | $1.3B | +5.1% |
| Q1 2025 | $1.1B | +3.5% |
| Q4 2024 | $1.3B | +9.1% |
BLCO's revenue has grown year over year for 15 quarters in a row: $1.4B last quarter, up 7.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +3.8 points |
| Q2 2026 | 6% | +6.8 points |
| Q1 2026 | 2.6% | +9.9 points |
| Q4 2025 | 8% | +1.2 points |
| Q3 2025 | 7.4% | +3.8 points |
| Q2 2025 | -0.9% | -3 points |
| Q1 2025 | -7.3% | -7.8 points |
| Q4 2024 | 6.8% | +2.6 points |
BLCO has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over BLCO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
BLCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $178M | +183% |
| Q2 2026 | $82M | +$136M |
| Q1 2026 | -$68M | +$67M |
| Q4 2025 | $60M | +$130M |
| Q3 2025 | $63M | -33% |
| Q2 2025 | -$54M | +$3M |
| Q1 2025 | -$135M | -$109M |
| Q4 2024 | -$70M | -$1M |
BLCO's free cash flow has turned positive after four years mostly in the red: $252M over the past year.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over BLCO on cash flow, with more consistent year-over-year improvement.
BLCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +4.4M shares |
| 1 year | +2.1% | +7.3M shares |
| 3 years | +3.1% | +10.7M shares |
| 5 years | +3.3% | +11.5M shares |
| Available history | +3.3% | +11.5M shares |
BLCO has 362M diluted shares, up 2.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over BLCO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
BLCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.7x | High |
| Q2 2026 | 6.4x | High |
| Q1 2026 | 7.4x | High |
| Q4 2025 | 8.7x | High |
| Q3 2025 | 9.0x | High |
| Q2 2025 | 10.1x | High |
| Q1 2025 | 9.2x | High |
| Q4 2024 | 7.5x | High |
BLCO's net debt is about 5.7 years of its operating earnings (EBITDA), down from 9.0 years a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
BLCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.1 | Overbought |
| Stochastic | 83.1 | Overbought |
BLCO's weekly RSI is 73 (overbought) and its Stochastic is 83 (overbought).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
BLCO PE vs Healthcare Sector
| Metric | BLCO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BLCO has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
BLCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.3 | 16% above |
| 20 week MA | $17.5 | 21% above |
| 50 week MA | $16.9 | 25% above |
| 100 week MA | $15.7 | 34% above |
| 200 week MA | $16.4 | 29% above |
BLCO has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
BLCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $20.0 | $14.6 | -27% |
| 2023 | $14.6 | $17.1 | +17% |
| 2024 | $17.1 | $18.0 | +5.3% |
| 2025 | $18.0 | $17.2 | -4.4% |
| 2026 YTD | $17.2 | $21.1 | +23% |
BLCO has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.